Article
Initial serum CA-125 and HE4 levels as predictors for optimal surgical cytoreduction in patients with stage III epithelial ovarian cancer
2022-09-30
Abstract excerpt
<h4>Background: </h4> Ovarian cancer (OC) lacks specific symptoms and screening methods, and most patients are diagnosed at an advanced stage with worse prognosis. Currently, the major treatment approaches for advanced epithelial ovarian carcinoma (AEOC) have been primary debulking surgery (PDS) followed by platinum-based chemotherapy, and neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 646d5955-c43f-5ac0-83c4-e969e6ad46a6
- DOI
- 10.21203/rs.3.rs-2108512/v1
